questioning aids

questioning and rethinking the orthodox HIV=AIDS theory

Dr. Jacques Leibowitch: 4 days a week is enough!

Dr. Jacques Leibowitch: 4 days a week is enough!

In the simplest possible summation, Leibowitch has been treating HIV-positive patients with traditional ARV cocktails, called HAART. Where he leaves the path of traditional treatment guidelines is that once a patient is “stabilised”—meaning they have achieved respectably high CD4 counts, and their viral load is undetectable for six months—Leibowitch starts reducing the number of days per week that a patient takes these drugs, to as little as twice per week.

Bathtubs, concrete cracks, bubble wrapped pills and magnolia blossoms

Bathtubs, concrete cracks, bubble wrapped pills and magnolia blossoms

I’m feeling… something. Older, perhaps? I fear I have so many things I want to accomplish so I can “retire” with some degree of comfort; a bathtub I can actually stretch out and soak in, for example.

I am still recovering from the sudden loss of Gos Blank and watching from a distance as other friends struggle with their own forms of bizarre and crippling health. It makes me feel I have no right or business to complain about my own symptoms and signs.

Higher CD4 count increases risk of ARV adverse effects

Higher CD4 count increases risk of ARV adverse effects

Each patient fell into one of three groups: <350 CD4 cells/muL; 351-499; and >500. This last group would be considered “normal” according to AIDS.gov, which lists the range for CD4 counts as 500-1000. Yet, according to this study, this group of so-called “healthy” patients were almost one and a half times more likely to experience a drug-related adverse effect.

The report reinforces another point that I find I must continue to drive home over and over again, and that is the definition of “low CD4 counts”.

Dr Ron scribbled "what has made the difference" on latest OAT test result.

Good news, mostly -UPDATED with video

The latest round of OAT, stool and conventional “HIV” surrogate test markers are in, and the news is mostly good. Regardless of which angle one looks at these laboratory test results from, there is evidence to support an evolving thesis that a multi-faceted approach to immune dysfunction might be as efficacious as the current pharmaceutical-based guidelines for treating “HIV/AIDS”, minus the worst of the adverse effects. The not-so-good news is that the continuation of this seven year long experience (experiment?) is being jeopardized by the lack of financial resources. There, I said it, and I won’t mention it again until the end of this post.

collage book cover - Fear of the Invisible

Fear of the Invisible & Alive and Well SF websites restored

Janine Roberts may well be my favorite investigative reporter on the topic of AIDS and HIV. She has published several books and produced documentary films, on topics ranging from Aboriginal resistance to British colonialism in Australia, to the shame of deBeers’ diamond mining operations in Africa.

Janine has also written the much more personal story about her life as a transgendered person—The Seven Days of My Creation: Tales of Magic and Gender

The book that has most helped me form an alternative view about what the heck HIV might really be, and its role in the disease most people call AIDS is titled Fear of the Invisible.

Man walking down railroad tracks

2014: time to move on beyond AIDS dissidence

As the winter solstice approaches, I am aware of what a noteworthy month this December is for me, in ways that have nothing to do with the holidays. Fifteen years ago this month I was informed that I was “HIV-positive”. Five years ago, I started this blog, primarily to share my experiences with both the diagnosis, as well as previous and new health issues. I will be sharing some exciting news about some changes that will be happening to resistance is fruitful a bit later in this post.

Borg ship

AIDS drugs: when resistance is futile

In nearly every conversation I’ve had with Affecteds who are experimenting with ways to reduce the toxicity of antiretroviral (ARV) regimens, questions about “AIDS drug resistance” comes up. Resistance is often raised as a boogeyman in research trials of monotherapy and intermittent treatment options. While drug resistance—especially bacterial antibiotic resistance to staphylococcus or tuberculosis, for example—is increasingly a problem in modern medicine, one is unlikely to hear drug resistance discussed quite the way it is with AIDS. No other pathogen is described as “sneaky”, “clever”, or more mutable than HIV, despite the fact that retroviruses do not even meet most definitions for being a living entity, let alone have a brain.

No! Nukes!!

AIDS drug guidelines: Stop the nukes!

Stop the nukes! No, not nuclear weapons. Well, yes, those too, but today I’m writing about the increase in reports I’m seeing from the AIDS drug medical literature calling for an end to the use of nucleoside(tide) reverse transcriptase inhibitors (NRTIs), not-so-ironically referred to as “nukes”. As I have written previously, there have been rumblings from clinicians and researchers in the medical literature since at least 2010 to get rid of the NRTI class of antiretroviral drugs entirely from treatment guidelines.

Unfortunately, it is unlikely that this change will occur at anything comparable to the speed with which AZT and other poison pills were “fast-tracked” to market more than 25 years ago.

Quitting drugs is not enough

  Some folks who have read my story about quitting AIDS drugs and nearly two dozen other prescription drugs seem to think I attribute my improved health to that choice alone. It isn’t that simple. There is no doubt in my mind that taking so many prescription drugs, even under the care of physicians,…

Graphic of AMAS logo with "NORMAL" stamped over it.

Cancer scare 2: CANCELLED

Very good news: I just received the results of the confirmatory AMAS cancer screen, and it was “normal”, or negative. In fact, the results were in the lowest possible range provided on the test. The result from my first AMAS test a couple of months ago was “elevated”, which required a confirmatory test. For obvious reasons, I have very mixed feelings about this test, but I am ready to put it behind me.